Work-up for unintentional weight loss
I've assumed you mean unintentional (unexplained) weight loss. If you meant a work-up for someone who wants to lose weight (obesity), tell me and I'll cover that instead.
1. Confirm the weight loss is real and significant
- Significant loss is more than 5% of usual body weight over 6-12 months. Loss above 10% is severe and suggests protein-energy malnutrition. (Symptom to Diagnosis: An Evidence Based Guide, 4th ed.; Sleisenger and Fordtran's Gastrointestinal and Liver Disease)
- Document it with old weights, or with changes in clothing or belt size. Family or caregiver history helps.
- 25-50% of people who complain of weight loss haven't actually lost weight. Older adults often lose muscle mass and just look thinner. (Symptom to Diagnosis)
- Patient estimates can mislead. Among patients who overestimated their loss, cancer was found in only 6%. Among those who underestimated it, cancer was found in 52%. (Symptom to Diagnosis)
- History alone is imperfect. One study found that a third of patients with true loss were missed by history. (Sleisenger and Fordtran's)
2. Think through the mechanism
- Stool changes. Diarrhea or greasy, foul-smelling stools suggest malabsorption, small bowel disease or pancreatic disease. Narrow stools or difficulty defecating suggest colorectal cancer.
- Intake versus expenditure.
- Most patients lose weight because they eat less. Causes include depression, dental problems, dysphagia, early satiety, dementia, medications, alcohol and social isolation.
- Loss despite normal or high intake points to a hypermetabolic or catabolic state, or to malabsorption. Think of cancer, hyperthyroidism, uncontrolled diabetes, severe COPD, chronic infection and malabsorption.
3. History and examination
Look for the "company it keeps":
- Review of systems: fever, night sweats, cough, hemoptysis, dysphagia, abdominal pain, bowel changes, GI bleeding, polyuria, palpitations.
- Medication history: SGLT2 inhibitors, GLP-1 agonists, metformin, diuretics, digoxin, SSRIs, stimulants, chemotherapy.
- Substances and exposures: alcohol, tobacco, drugs, TB or HIV risk, travel.
- Psychosocial: mood (PHQ-2 or PHQ-9), cognition, eating disorder, finances, ability to shop and cook, dentition.
- Examination:
- Full head-to-toe exam, with attention to mental status.
- Oral and dental exam, thyroid, lymph nodes, breast, abdomen (masses, organomegaly), rectal exam, skin, and neurologic and joint findings.
- Check that cancer screening is up to date (mammogram, Pap/HPV, colonoscopy, PSA where appropriate).
4. Baseline investigations
The standard first-line battery is:
- CBC with differential
- Chemistry panel: renal function, calcium, glucose
- Liver panel
- TSH
- ESR and CRP
- Urinalysis
- Fecal occult blood test
- HIV test where appropriate
- Chest X-ray
- Abdominal ultrasound, which several studies added
This battery was 93% sensitive for detecting cancer in patients with unintentional weight loss. If it is negative, the rate of occult cancer is under 5%. (Symptom to Diagnosis)
Add these only if indicated:
- Ferritin, B12, folate and celiac serology if malabsorption is suspected.
- Stool studies and fecal elastase.
- HbA1c.
- Cortisol if adrenal insufficiency is suspected.
- Blood cultures, TB testing and ANA/ANCA if infection or autoimmune disease is suspected.
- SPEP if myeloma is suspected.
5. Targeted follow-up of abnormal findings
| Finding | Next step |
|---|
| Iron deficiency anemia, GI symptoms or positive FOBT | EGD and colonoscopy |
| Early satiety, dysphagia or epigastric pain | EGD, plus H. pylori testing |
| Abdominal pain, jaundice or abnormal LFTs | Abdominal CT or ultrasound |
| Cough, hemoptysis or smoking history | Chest CT |
| Suppressed TSH | Free T4 and T3 |
| High ESR | Consider myeloma, giant cell arteritis, endocarditis and chronic infection |
| High alkaline phosphatase | Consider liver or bone metastases |
| Hematuria | Evaluate for kidney or bladder cancer |
| Low mood | Treat depression |
EGD yield in unintentional weight loss is 12-44%, and it is higher in the absence of epigastric pain. (Symptom to Diagnosis)
6. Common causes
- Cancer: about 19-36%. It is mostly GI, then lung and lymphoma.
- Depression and alcoholism: about 16%.
- Non-malignant GI disease: about 13%.
- Endocrine disease: about 7%.
- No cause found: about 22%.
Other causes to remember are dementia, frailty, chronic infection (TB, HIV), heart failure, COPD, kidney disease and medications.
7. If the work-up is negative
- Cancer is unlikely after a negative initial evaluation with appropriate follow-up of any abnormalities.
- Don't keep ordering tests. Reassess in 1-3 months with serial weights and repeat the history.
- Offer nutritional support, dietitian input and treatment of any contributors. Artificial nutrition mainly helps patients with a reversible mechanical cause of poor intake. Examples are head and neck cancer after radiotherapy, bowel obstruction, and upper GI surgery.
- Revisit the work-up if the weight loss continues.
Recent evidence check
The PubMed search for recent systematic reviews found nothing that overturns this approach. It did turn up a
2026 meta-analysis of pre-diagnostic weight loss in pancreatic cancer (PMID 42174848). That supports a low threshold for pancreatic imaging when weight loss comes with abdominal pain, new diabetes or jaundice. A
2025 malnutrition diagnostic guideline (PMID 41038675) is also relevant if the problem is nutritional. I only read the titles and metadata, not the full papers.
I can also tailor this to a specific scenario, such as an older adult, a cancer-suspicion pathway, or an obesity-management work-up.